Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Related content
Volume 10, Number 7, November 2010

< previous issue | all issues | next issue >

Articles

Favourites:Add to Favourites

Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases
pp. 649-659(11)
Authors: Salerno, M.; Cenni, E.; Fotia, C.; Avnet, S.; Granchi, D.; Castelli, F.; Micieli, D.; Pignatello, R.; Capulli, M.; Rucci, N.; Angelucci, A.; Del Fattore, A.; Teti, A.; Zini, N.; Giunti, A.; Baldini, N.

Favourites:Add to Favourites

Oxaliplatin-mediated Inhibition of Survivin Increases Sensitivity of Head and Neck Squamous Cell Carcinoma Cell Lines to Paclitaxel
pp. 660-669(10)
Authors: Khan, Z.; Khan, N.; K. Varma, A.; P. Tiwari, R.; Mouhamad, S.; B.K.S. Prasad, G.; S. Bisen, P.

Favourites:Add to Favourites

The Role of Oxidative Stress and Anti-Oxidant Treatment in Platinum-Induced Peripheral Neurotoxicity
pp. 670-682(13)
Authors: A. Carozzi, V.; Marmiroli, P.; Cavaletti, G.

Favourites:Add to Favourites

Is Src a Viable Target for Treating Solid Tumours?
pp. 683-694(12)
Authors: Elsberger, B.; Stewart, B.; Tatarov, O.; Edwards, J.

Favourites:Add to Favourites

Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept
pp. 695-704(10)
Authors: Falciani, C.; Lelli, B.; Brunetti, J.; Pileri, S.; Cappelli, A.; Pini, A.; Pagliuca, C.; Ravenni, N.; Bencini, L.; Menichetti, S.; Moretti, R.; De Prizio, M.; Scatizzi, M.; Bracci, L.

Favourites:Add to Favourites

Wnt/β-Catenin/LEF-1 Signaling in Chronic Lymphocytic Leukemia (CLL): A Target for Current and Potential Therapeutic Options
pp. 716-727(12)
Authors: K. Gandhirajan, R.; J. Poll-Wolbeck, S.; Gehrke, I.; Kreuzer, K.-A.

Favourites:Add to Favourites

New Insights of CTLA-4 into Its Biological Function in Breast Cancer
pp. 728-736(9)
Authors: Mao, H.; Zhang, L.; Yang, Y.; Zuo, W.; Bi, Y.; Gao, W.; Deng, B.; Sun, J.; Shao, Q.; Qu, X.

Favourites:Add to Favourites

Dynamic Simulations of Pathways Downstream of ERBB-Family, Including Mutations and Treatments: Concordance with Experimental Results
pp. 737-757(21)
Authors: Castagnino, N.; Tortolina, L.; Balbi, A.; Pesenti, R.; Montagna, R.; Ballestrero, A.; Soncini, D.; Moran, E.; Nencioni, A.; Parodi, S.

Favourites:Add to Favourites

DNA Topoisomerase II Enzymes as Molecular Targets for Cancer Chemotherapy
pp. 758-771(14)
Authors: Chikamori, K.; G. Grozav, A.; Kozuki, T.; Grabowski, D.; Ganapathi, R.; K. Ganapathi, M.

Favourites:Add to Favourites

Concomitant CXCR4 and CXCR7 Expression Predicts Poor Prognosis in Renal Cancer
pp. 772-781(10)
Authors: D'Alterio, C.; Consales, C.; Polimeno, M.; Franco, R.; Cindolo, L.; Portella, L.; Cioffi, M.; Calemma, R.; Marra, L.; Claudio, L.; Perdona, S.; Pignata, S.; Facchini, G.; Carteni, G.; Longo, N.; Pucci, L.; Ottaiano, A.; Costantini, S.; Castello, G.; Scala, S.

Favourites:Add to Favourites

Cancer Therapy By Targeting Hypoxia-Inducible Factor-1
pp. 782-796(15)
Authors: Li, Y.; Ye, D.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more